Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (871-880 of 910) with videos related to

Pageof 91
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalitiesR S Devon, P C Orban, K Gerrow, et al.
The Pharmacogenomics Journal|May 28, 2014
Pharmacogenomic diversity in Singaporean populations and EuropeansL R Brunham, S L Chan, R Li, et al.
Science Translational Medicine|October 5, 2018
Huntingtin suppression restores cognitive function in a mouse model of Huntington's diseaseAmber L Southwell, Holly B Kordasiewicz, Douglas Langbehn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington diseaseNicholas S Caron, Amirah E-E Aly, Hailey Findlay Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
The Journal of Biological Chemistry|May 16, 1998
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tractC L Wellington, L M Ellerby, A S Hackam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET studyIgor D Grachev, Philipp M Meyer, Georg A Becker, et al.
Cell Death and Differentiation|April 14, 1999
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complexD M Rasper, J P Vaillancourt, S Hadano, et al.
Atherosclerosis|March 6, 2010
Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosisSander I van Leuven, Diederik F van Wijk, Oscar L Volger, et al.
Pageof 91

Showing results (871-880 of 910) with videos related to

Sort By:
Pageof 91
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalitiesR S Devon, P C Orban, K Gerrow, et al.
The Pharmacogenomics Journal|May 28, 2014
Pharmacogenomic diversity in Singaporean populations and EuropeansL R Brunham, S L Chan, R Li, et al.
Science Translational Medicine|October 5, 2018
Huntingtin suppression restores cognitive function in a mouse model of Huntington's diseaseAmber L Southwell, Holly B Kordasiewicz, Douglas Langbehn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington diseaseNicholas S Caron, Amirah E-E Aly, Hailey Findlay Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
The Journal of Biological Chemistry|May 16, 1998
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tractC L Wellington, L M Ellerby, A S Hackam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET studyIgor D Grachev, Philipp M Meyer, Georg A Becker, et al.
Cell Death and Differentiation|April 14, 1999
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complexD M Rasper, J P Vaillancourt, S Hadano, et al.
Atherosclerosis|March 6, 2010
Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosisSander I van Leuven, Diederik F van Wijk, Oscar L Volger, et al.
Pageof 91